DD267036A5 - Verfahren zur herstellung von carbonsaeurederivaten - Google Patents
Verfahren zur herstellung von carbonsaeurederivaten Download PDFInfo
- Publication number
- DD267036A5 DD267036A5 DD88312165A DD31216588A DD267036A5 DD 267036 A5 DD267036 A5 DD 267036A5 DD 88312165 A DD88312165 A DD 88312165A DD 31216588 A DD31216588 A DD 31216588A DD 267036 A5 DD267036 A5 DD 267036A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- acid
- group
- general formula
- chain
- alkylene group
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 19
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- 150000001875 compounds Chemical class 0.000 claims abstract description 38
- 150000002148 esters Chemical class 0.000 claims abstract description 18
- 150000001408 amides Chemical class 0.000 claims abstract description 13
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims abstract description 13
- 150000003839 salts Chemical class 0.000 claims abstract description 13
- 229910052727 yttrium Inorganic materials 0.000 claims abstract description 9
- 239000003814 drug Substances 0.000 claims abstract description 8
- 238000011282 treatment Methods 0.000 claims abstract description 8
- 229910052721 tungsten Inorganic materials 0.000 claims abstract description 7
- 238000004519 manufacturing process Methods 0.000 claims abstract description 4
- 229910052740 iodine Inorganic materials 0.000 claims abstract description 3
- 208000030159 metabolic disease Diseases 0.000 claims abstract description 3
- -1 cycloalkoxy radical Chemical class 0.000 claims description 100
- 125000002947 alkylene group Chemical group 0.000 claims description 23
- 125000004432 carbon atom Chemical group C* 0.000 claims description 19
- 229920006395 saturated elastomer Polymers 0.000 claims description 15
- 229910052739 hydrogen Inorganic materials 0.000 claims description 13
- 239000001257 hydrogen Substances 0.000 claims description 13
- 125000005842 heteroatom Chemical group 0.000 claims description 12
- 150000003254 radicals Chemical group 0.000 claims description 11
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 8
- 125000004429 atom Chemical group 0.000 claims description 8
- 125000000217 alkyl group Chemical group 0.000 claims description 7
- 229910052799 carbon Inorganic materials 0.000 claims description 7
- 229910052736 halogen Inorganic materials 0.000 claims description 7
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 7
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 6
- 150000002367 halogens Chemical class 0.000 claims description 6
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical compound [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 claims description 5
- 238000009833 condensation Methods 0.000 claims description 5
- 230000005494 condensation Effects 0.000 claims description 5
- 150000002431 hydrogen Chemical group 0.000 claims description 5
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 5
- 125000003545 alkoxy group Chemical group 0.000 claims description 4
- 125000004414 alkyl thio group Chemical group 0.000 claims description 4
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 4
- 230000000694 effects Effects 0.000 claims description 4
- 125000003107 substituted aryl group Chemical group 0.000 claims description 4
- 125000004644 alkyl sulfinyl group Chemical group 0.000 claims description 3
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 3
- 125000003282 alkyl amino group Chemical group 0.000 claims description 2
- 125000005135 aryl sulfinyl group Chemical group 0.000 claims description 2
- 125000004391 aryl sulfonyl group Chemical group 0.000 claims description 2
- 125000005110 aryl thio group Chemical group 0.000 claims description 2
- 125000004104 aryloxy group Chemical group 0.000 claims description 2
- 229910052717 sulfur Inorganic materials 0.000 claims description 2
- 125000004434 sulfur atom Chemical group 0.000 claims description 2
- 125000003368 amide group Chemical group 0.000 claims 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 claims 1
- 125000005843 halogen group Chemical group 0.000 claims 1
- 125000000040 m-tolyl group Chemical group [H]C1=C([H])C(*)=C([H])C(=C1[H])C([H])([H])[H] 0.000 claims 1
- 125000003261 o-tolyl group Chemical group [H]C1=C([H])C(*)=C(C([H])=C1[H])C([H])([H])[H] 0.000 claims 1
- 239000004577 thatch Substances 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 35
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 31
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 24
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 21
- 239000002253 acid Substances 0.000 description 16
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 16
- 239000000203 mixture Substances 0.000 description 16
- MNWFXJYAOYHMED-UHFFFAOYSA-N heptanoic acid Chemical compound CCCCCCC(O)=O MNWFXJYAOYHMED-UHFFFAOYSA-N 0.000 description 14
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 12
- 125000006418 4-methylphenylsulfonyl group Chemical group 0.000 description 11
- WWZKQHOCKIZLMA-UHFFFAOYSA-N Caprylic acid Natural products CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 11
- 150000001735 carboxylic acids Chemical class 0.000 description 11
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 10
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 9
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- 239000002904 solvent Substances 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- 239000003921 oil Substances 0.000 description 8
- 235000019198 oils Nutrition 0.000 description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 7
- 150000001298 alcohols Chemical class 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 6
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 6
- 239000012230 colorless oil Substances 0.000 description 6
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 6
- GONOPSZTUGRENK-UHFFFAOYSA-N benzyl(trichloro)silane Chemical compound Cl[Si](Cl)(Cl)CC1=CC=CC=C1 GONOPSZTUGRENK-UHFFFAOYSA-N 0.000 description 5
- FUZZWVXGSFPDMH-UHFFFAOYSA-N n-hexanoic acid Natural products CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- 229910052708 sodium Inorganic materials 0.000 description 5
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 5
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 4
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 150000001412 amines Chemical class 0.000 description 4
- 150000005840 aryl radicals Chemical class 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 description 4
- 239000000460 chlorine Substances 0.000 description 4
- 125000004494 ethyl ester group Chemical group 0.000 description 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 3
- GVNVAWHJIKLAGL-UHFFFAOYSA-N 2-(cyclohexen-1-yl)cyclohexan-1-one Chemical compound O=C1CCCCC1C1=CCCCC1 GVNVAWHJIKLAGL-UHFFFAOYSA-N 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 101150065749 Churc1 gene Proteins 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 3
- 102100038239 Protein Churchill Human genes 0.000 description 3
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 3
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N Valeric acid Natural products CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 3
- 229960000583 acetic acid Drugs 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N acetic acid anhydride Natural products CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- 125000006125 ethylsulfonyl group Chemical group 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 235000019260 propionic acid Nutrition 0.000 description 3
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 3
- 238000007127 saponification reaction Methods 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- 238000005809 transesterification reaction Methods 0.000 description 3
- 125000000590 4-methylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 description 2
- 229940123208 Biguanide Drugs 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 229910001854 alkali hydroxide Inorganic materials 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 150000003973 alkyl amines Chemical class 0.000 description 2
- 229960004050 aminobenzoic acid Drugs 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 150000008064 anhydrides Chemical class 0.000 description 2
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 229940000635 beta-alanine Drugs 0.000 description 2
- 150000004283 biguanides Chemical class 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 125000005265 dialkylamine group Chemical group 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000032050 esterification Effects 0.000 description 2
- 238000005886 esterification reaction Methods 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 239000012362 glacial acetic acid Substances 0.000 description 2
- 150000004820 halides Chemical class 0.000 description 2
- 229920006158 high molecular weight polymer Polymers 0.000 description 2
- 239000012442 inert solvent Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 150000007529 inorganic bases Chemical class 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 125000005948 methanesulfonyloxy group Chemical group 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- HUPQYPMULVBQDL-UHFFFAOYSA-N pentanoic acid Chemical compound CCCCC(O)=O.CCCCC(O)=O HUPQYPMULVBQDL-UHFFFAOYSA-N 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000002798 polar solvent Substances 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 2
- NDVLTYZPCACLMA-UHFFFAOYSA-N silver oxide Chemical compound [O-2].[Ag+].[Ag+] NDVLTYZPCACLMA-UHFFFAOYSA-N 0.000 description 2
- 239000012312 sodium hydride Substances 0.000 description 2
- 229910000104 sodium hydride Inorganic materials 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- TZLFMUNFVPZWRJ-UHFFFAOYSA-N (3-methylphenyl)sulfonyl octanoate Chemical compound C(CCCCCCC)(=O)OS(=O)(=O)C1=CC(=CC=C1)C TZLFMUNFVPZWRJ-UHFFFAOYSA-N 0.000 description 1
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- WVSYQCITZUEVAS-UHFFFAOYSA-N 1-(6-bromohexyl)-4-chlorobenzene Chemical compound ClC1=CC=C(CCCCCCBr)C=C1 WVSYQCITZUEVAS-UHFFFAOYSA-N 0.000 description 1
- MRCKDGXKYBOAHJ-UHFFFAOYSA-N 1-bromo-6-methoxyhexane Chemical compound COCCCCCCBr MRCKDGXKYBOAHJ-UHFFFAOYSA-N 0.000 description 1
- CAHTXDXWVFGCFL-UHFFFAOYSA-N 1-bromo-6-methylsulfanylhexane Chemical compound CSCCCCCCBr CAHTXDXWVFGCFL-UHFFFAOYSA-N 0.000 description 1
- XYPISWUKQGWYGX-UHFFFAOYSA-N 2,2,2-trifluoroethaneperoxoic acid Chemical compound OOC(=O)C(F)(F)F XYPISWUKQGWYGX-UHFFFAOYSA-N 0.000 description 1
- NEMMVKSHJGMOCB-UHFFFAOYSA-N 2,6-bis(4-chlorophenoxy)hexanoic acid 6-(4-chlorophenoxy)-2-(4-methylphenyl)sulfanylhexanoic acid Chemical compound ClC1=CC=C(OCCCCC(C(=O)O)SC2=CC=C(C=C2)C)C=C1.ClC1=CC=C(OCCCCC(C(=O)O)OC2=CC=C(C=C2)Cl)C=C1 NEMMVKSHJGMOCB-UHFFFAOYSA-N 0.000 description 1
- IRFUNABYADZWPB-UHFFFAOYSA-N 2-(4-methylphenyl)sulfanyl-4-(2-phenylethoxy)butanoic acid Chemical compound C1=CC(C)=CC=C1SC(C(O)=O)CCOCCC1=CC=CC=C1 IRFUNABYADZWPB-UHFFFAOYSA-N 0.000 description 1
- YFUZQJQXZPWRJE-UHFFFAOYSA-N 2-(4-methylphenyl)sulfonylbutanoic acid Chemical compound CCC(C(O)=O)S(=O)(=O)C1=CC=C(C)C=C1 YFUZQJQXZPWRJE-UHFFFAOYSA-N 0.000 description 1
- VNNJWMSSOLEVRI-UHFFFAOYSA-N 2-(4-tert-butylphenoxy)-6-(4-chlorophenoxy)hexanoic acid Chemical compound C1=CC(C(C)(C)C)=CC=C1OC(C(O)=O)CCCCOC1=CC=C(Cl)C=C1 VNNJWMSSOLEVRI-UHFFFAOYSA-N 0.000 description 1
- GTVAMRIODYMSGH-UHFFFAOYSA-N 2-(4-tert-butylphenoxy)-7-(4-chlorophenyl)heptanoic acid Chemical compound C1=CC(C(C)(C)C)=CC=C1OC(C(O)=O)CCCCCC1=CC=C(Cl)C=C1 GTVAMRIODYMSGH-UHFFFAOYSA-N 0.000 description 1
- DNHBCGCCHBKOLL-UHFFFAOYSA-N 2-(4-tert-butylphenyl)sulfanyl-7-(4-chlorophenyl)heptanoic acid 7-(4-chlorophenyl)-2-(2-phenylethylsulfanyl)heptanoic acid Chemical compound ClC1=CC=C(C=C1)CCCCCC(C(=O)O)SCCC1=CC=CC=C1.ClC1=CC=C(C=C1)CCCCCC(C(=O)O)SC1=CC=C(C=C1)C(C)(C)C DNHBCGCCHBKOLL-UHFFFAOYSA-N 0.000 description 1
- LHTKCBGBIXAJDF-UHFFFAOYSA-N 2-(4-tert-butylphenyl)sulfanyl-8-(4-chlorophenyl)octanoic acid 8-(4-chlorophenyl)-2-(2-methylphenyl)sulfonyloctanoic acid 8-(4-chlorophenyl)-2-(2-phenylethylsulfanyl)octanoic acid Chemical compound ClC1=CC=C(C=C1)CCCCCCC(C(=O)O)S(=O)(=O)C1=C(C=CC=C1)C.ClC1=CC=C(C=C1)CCCCCCC(C(=O)O)SCCC1=CC=CC=C1.ClC1=CC=C(C=C1)CCCCCCC(C(=O)O)SC1=CC=C(C=C1)C(C)(C)C LHTKCBGBIXAJDF-UHFFFAOYSA-N 0.000 description 1
- JVAPIGLHVPRHLX-UHFFFAOYSA-N 2-(4-tert-butylphenyl)sulfonyl-7-(4-chlorophenyl)heptanoic acid 7-(4-chlorophenyl)-2-octylsulfonylheptanoic acid 7-(4-chlorophenyl)-2-(2-phenylethylsulfonyl)heptanoic acid Chemical compound ClC1=CC=C(C=C1)CCCCCC(C(=O)O)S(=O)(=O)CCC1=CC=CC=C1.ClC1=CC=C(C=C1)CCCCCC(C(=O)O)S(=O)(=O)C1=CC=C(C=C1)C(C)(C)C.ClC1=CC=C(C=C1)CCCCCC(C(=O)O)S(=O)(=O)CCCCCCCC JVAPIGLHVPRHLX-UHFFFAOYSA-N 0.000 description 1
- QUYRFVULNLURAA-UHFFFAOYSA-N 2-(4-tert-butylphenyl)sulfonyl-8-phenyloctanoic acid 8-phenyl-2-(2-phenylethylsulfonyl)octanoic acid Chemical compound C1(=CC=CC=C1)CCCCCCC(C(=O)O)S(=O)(=O)CCC1=CC=CC=C1.C1(=CC=CC=C1)CCCCCCC(C(=O)O)S(=O)(=O)C1=CC=C(C=C1)C(C)(C)C QUYRFVULNLURAA-UHFFFAOYSA-N 0.000 description 1
- BKMMTJMQCTUHRP-UHFFFAOYSA-N 2-aminopropan-1-ol Chemical compound CC(N)CO BKMMTJMQCTUHRP-UHFFFAOYSA-N 0.000 description 1
- RIWRDIWMEGKUEV-UHFFFAOYSA-N 2-phenoxy-5-phenylpentanoic acid Chemical compound C=1C=CC=CC=1OC(C(=O)O)CCCC1=CC=CC=C1 RIWRDIWMEGKUEV-UHFFFAOYSA-N 0.000 description 1
- 125000005975 2-phenylethyloxy group Chemical group 0.000 description 1
- 125000001241 2-phenylethylthio group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])S* 0.000 description 1
- 125000005977 3-phenylpropyloxy group Chemical group 0.000 description 1
- XKEZMFNQLIUODN-UHFFFAOYSA-N 4-[2-(4-chlorophenyl)ethoxy]-2-(4-methylphenyl)sulfonylbutanoic acid Chemical compound C1=CC(C)=CC=C1S(=O)(=O)C(C(O)=O)CCOCCC1=CC=C(Cl)C=C1 XKEZMFNQLIUODN-UHFFFAOYSA-N 0.000 description 1
- OKXWCSLHMYRXLR-UHFFFAOYSA-N 4-[2-(4-chlorophenyl)ethoxy]-2-hexylsulfonylbutanoic acid Chemical compound CCCCCCS(=O)(=O)C(C(O)=O)CCOCCC1=CC=C(Cl)C=C1 OKXWCSLHMYRXLR-UHFFFAOYSA-N 0.000 description 1
- QYTGORGILSHKID-UHFFFAOYSA-N 5-(4-tert-butylphenyl)-2-(4-methylphenyl)sulfonylpent-4-ynoic acid Chemical compound C1=CC(C)=CC=C1S(=O)(=O)C(C(O)=O)CC#CC1=CC=C(C(C)(C)C)C=C1 QYTGORGILSHKID-UHFFFAOYSA-N 0.000 description 1
- LXVRBJBNRAMCCD-UHFFFAOYSA-N 6-(4-chlorophenoxy)-2-(4-methylphenoxy)hexanoic acid Chemical compound C1=CC(C)=CC=C1OC(C(O)=O)CCCCOC1=CC=C(Cl)C=C1 LXVRBJBNRAMCCD-UHFFFAOYSA-N 0.000 description 1
- WBXNALANKOVQGS-UHFFFAOYSA-N 6-cyclohexyl-2-(4-methylphenyl)sulfonylhexanoic acid Chemical compound C1=CC(C)=CC=C1S(=O)(=O)C(C(O)=O)CCCCC1CCCCC1 WBXNALANKOVQGS-UHFFFAOYSA-N 0.000 description 1
- PVDNXCQIVKWAMG-UHFFFAOYSA-N 7-(4-chlorophenoxy)-2-(4-methylphenoxy)heptanoic acid Chemical compound C1=CC(C)=CC=C1OC(C(O)=O)CCCCCOC1=CC=C(Cl)C=C1 PVDNXCQIVKWAMG-UHFFFAOYSA-N 0.000 description 1
- FOZBLXYBODKMKR-UHFFFAOYSA-N 7-(4-chlorophenyl)-2-(2-methylphenyl)sulfanylheptanoic acid 7-(4-chlorophenyl)-2-(2-phenylethoxy)heptanoic acid Chemical compound ClC1=CC=C(C=C1)CCCCCC(C(=O)O)SC1=C(C=CC=C1)C.ClC1=CC=C(C=C1)CCCCCC(C(=O)O)OCCC1=CC=CC=C1 FOZBLXYBODKMKR-UHFFFAOYSA-N 0.000 description 1
- KNFBEPCPVWDQTE-UHFFFAOYSA-N 7-(4-methoxyphenyl)-2-(2-phenylethylsulfonyl)heptanoic acid Chemical compound C1=CC(OC)=CC=C1CCCCCC(C(O)=O)S(=O)(=O)CCC1=CC=CC=C1 KNFBEPCPVWDQTE-UHFFFAOYSA-N 0.000 description 1
- YPLNRXMDQXUDAR-UHFFFAOYSA-N 7-(4-methoxyphenyl)-2-[2-(4-methylphenyl)ethylsulfonyl]heptanoic acid Chemical compound C1=CC(OC)=CC=C1CCCCCC(C(O)=O)S(=O)(=O)CCC1=CC=C(C)C=C1 YPLNRXMDQXUDAR-UHFFFAOYSA-N 0.000 description 1
- OBCHZUFIQJDZRN-UHFFFAOYSA-N 8-(4-chlorophenyl)-2-[2-(4-chlorophenyl)ethylsulfonyl]octanoic acid Chemical compound C=1C=C(Cl)C=CC=1CCS(=O)(=O)C(C(=O)O)CCCCCCC1=CC=C(Cl)C=C1 OBCHZUFIQJDZRN-UHFFFAOYSA-N 0.000 description 1
- IEJGDZOKYVOYLP-UHFFFAOYSA-N 8-(4-chlorophenyl)-2-[2-(4-methoxyphenyl)ethylsulfonyl]octanoic acid Chemical compound C1=CC(OC)=CC=C1CCS(=O)(=O)C(C(O)=O)CCCCCCC1=CC=C(Cl)C=C1 IEJGDZOKYVOYLP-UHFFFAOYSA-N 0.000 description 1
- IOZCVARTBDRETE-UHFFFAOYSA-N 8-(4-chlorophenyl)-2-[2-(4-methylphenyl)ethylsulfonyl]octanoic acid Chemical compound C1=CC(C)=CC=C1CCS(=O)(=O)C(C(O)=O)CCCCCCC1=CC=C(Cl)C=C1 IOZCVARTBDRETE-UHFFFAOYSA-N 0.000 description 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
- UZHNHDCYUXUOLJ-UHFFFAOYSA-N 8-methoxy-2-(4-methylphenoxy)octanoic acid Chemical compound COCCCCCCC(C(O)=O)OC1=CC=C(C)C=C1 UZHNHDCYUXUOLJ-UHFFFAOYSA-N 0.000 description 1
- DENCWIMPRCFQPR-UHFFFAOYSA-N 8-methoxy-2-(4-methylphenyl)sulfonyloctanoic acid Chemical compound COCCCCCCC(C(O)=O)S(=O)(=O)C1=CC=C(C)C=C1 DENCWIMPRCFQPR-UHFFFAOYSA-N 0.000 description 1
- NTKNCBWGVSSTKK-UHFFFAOYSA-N 8-phenyl-2-(4-propylphenyl)sulfonyloctanoic acid Chemical compound C1=CC(CCC)=CC=C1S(=O)(=O)C(C(O)=O)CCCCCCC1=CC=CC=C1 NTKNCBWGVSSTKK-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 description 1
- UAHGJOIDNLAEBZ-UHFFFAOYSA-N C(CCCC)OCCC(C(=O)O)S(=O)(=O)C1=CC=C(C=C1)C.CNCCCCCCC(C(=O)O)S(=O)(=O)C1=CC=C(C=C1)C Chemical compound C(CCCC)OCCC(C(=O)O)S(=O)(=O)C1=CC=C(C=C1)C.CNCCCCCCC(C(=O)O)S(=O)(=O)C1=CC=C(C=C1)C UAHGJOIDNLAEBZ-UHFFFAOYSA-N 0.000 description 1
- CEOANWPTCDXQSU-UHFFFAOYSA-N C1(=CC=CC=C1)CCCCCC(C(=O)O)S(=O)(=O)CC1=CC=CC=C1.C1(=CC=CC=C1)CCCCCC(C(=O)O)SCCC1=CC=CC=C1.C1(=CC=CC=C1)CCCCCC(C(=O)O)OCCC1=CC=CC=C1 Chemical compound C1(=CC=CC=C1)CCCCCC(C(=O)O)S(=O)(=O)CC1=CC=CC=C1.C1(=CC=CC=C1)CCCCCC(C(=O)O)SCCC1=CC=CC=C1.C1(=CC=CC=C1)CCCCCC(C(=O)O)OCCC1=CC=CC=C1 CEOANWPTCDXQSU-UHFFFAOYSA-N 0.000 description 1
- BHAFNPKGNKLXJQ-UHFFFAOYSA-N C1(=CC=CC=C1)CCCOCC(C(=O)O)OC1=CC=C(C=C1)C.C1(=CC=CC=C1)CCOCC(C(=O)O)S(=O)(=O)C1=CC=C(C=C1)C.C1(=CC=CC=C1)CCOCC(C(=O)O)OC1=CC=C(C=C1)C.C(CCCCCC)(=O)O Chemical compound C1(=CC=CC=C1)CCCOCC(C(=O)O)OC1=CC=C(C=C1)C.C1(=CC=CC=C1)CCOCC(C(=O)O)S(=O)(=O)C1=CC=C(C=C1)C.C1(=CC=CC=C1)CCOCC(C(=O)O)OC1=CC=C(C=C1)C.C(CCCCCC)(=O)O BHAFNPKGNKLXJQ-UHFFFAOYSA-N 0.000 description 1
- OZLFDPYETFFTAR-UHFFFAOYSA-N CC1=CC=C(OCCCCCC(C(=O)O)S(=O)(=O)C2=CC=C(C=C2)C)C=C1.CC1=CC=C(OCCCCCC(C(=O)O)SC2=CC=C(C=C2)C)C=C1.CC1=CC=C(OCCCCCC(C(=O)O)OC2=CC=C(C=C2)C)C=C1 Chemical compound CC1=CC=C(OCCCCCC(C(=O)O)S(=O)(=O)C2=CC=C(C=C2)C)C=C1.CC1=CC=C(OCCCCCC(C(=O)O)SC2=CC=C(C=C2)C)C=C1.CC1=CC=C(OCCCCCC(C(=O)O)OC2=CC=C(C=C2)C)C=C1 OZLFDPYETFFTAR-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- CRCNOAJLPMVQFY-UHFFFAOYSA-N ClC1=CC=C(C=C1)C#CCC(C(=O)O)S(=O)(=O)CC=CC1=CC=C(C=C1)Cl.ClC1=CC=C(C=C1)C#CCC(C(=O)O)S(=O)(=O)CCC1=CC=CC=C1 Chemical compound ClC1=CC=C(C=C1)C#CCC(C(=O)O)S(=O)(=O)CC=CC1=CC=C(C=C1)Cl.ClC1=CC=C(C=C1)C#CCC(C(=O)O)S(=O)(=O)CCC1=CC=CC=C1 CRCNOAJLPMVQFY-UHFFFAOYSA-N 0.000 description 1
- CESNRANVAKWJNS-UHFFFAOYSA-N ClC1=CC=C(C=C1)CCCCCC(C(=O)O)S(=O)(=O)C(C)(C)C.ClC1=CC=C(C=C1)CCCCCC(C(=O)O)S(=O)(=O)CCCC.ClC1=CC=C(C=C1)CCCCCC(C(=O)O)S(=O)(=O)CC Chemical compound ClC1=CC=C(C=C1)CCCCCC(C(=O)O)S(=O)(=O)C(C)(C)C.ClC1=CC=C(C=C1)CCCCCC(C(=O)O)S(=O)(=O)CCCC.ClC1=CC=C(C=C1)CCCCCC(C(=O)O)S(=O)(=O)CC CESNRANVAKWJNS-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 241000206672 Gelidium Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 239000007868 Raney catalyst Substances 0.000 description 1
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 1
- 229910000564 Raney nickel Inorganic materials 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 229910052776 Thorium Inorganic materials 0.000 description 1
- JAWMENYCRQKKJY-UHFFFAOYSA-N [3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-ylmethyl)-1-oxa-2,8-diazaspiro[4.5]dec-2-en-8-yl]-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]methanone Chemical compound N1N=NC=2CN(CCC=21)CC1=NOC2(C1)CCN(CC2)C(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F JAWMENYCRQKKJY-UHFFFAOYSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 229910001860 alkaline earth metal hydroxide Inorganic materials 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 150000001414 amino alcohols Chemical class 0.000 description 1
- 125000003277 amino group Chemical class 0.000 description 1
- 125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 description 1
- 229960000510 ammonia Drugs 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- 230000003178 anti-diabetic effect Effects 0.000 description 1
- 239000003416 antiarrhythmic agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 125000003710 aryl alkyl group Chemical group 0.000 description 1
- 125000002619 bicyclic group Chemical group 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- RDHPKYGYEGBMSE-UHFFFAOYSA-N bromoethane Chemical compound CCBr RDHPKYGYEGBMSE-UHFFFAOYSA-N 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 125000002837 carbocyclic group Chemical group 0.000 description 1
- 150000001733 carboxylic acid esters Chemical class 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000008139 complexing agent Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000002933 cyclohexyloxy group Chemical group C1(CCCCC1)O* 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 238000006114 decarboxylation reaction Methods 0.000 description 1
- 125000004663 dialkyl amino group Chemical group 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229940031098 ethanolamine Drugs 0.000 description 1
- 239000012259 ether extract Substances 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- DKBHHMLGBAWFQI-UHFFFAOYSA-N ethyl 2-(3-methylphenyl)sulfonylacetate Chemical compound CCOC(=O)CS(=O)(=O)C1=CC=CC(C)=C1 DKBHHMLGBAWFQI-UHFFFAOYSA-N 0.000 description 1
- PRZXYLNECKOIJI-UHFFFAOYSA-N ethyl 2-(4-methylphenyl)sulfonyl-8-methylsulfanyloctanoate Chemical compound CSCCCCCCC(C(=O)OCC)S(=O)(=O)C1=CC=C(C)C=C1 PRZXYLNECKOIJI-UHFFFAOYSA-N 0.000 description 1
- OGBGRFOKRVIXOX-UHFFFAOYSA-N ethyl 2-(4-methylphenyl)sulfonyl-8-methylsulfonyloctanoate Chemical compound CS(=O)(=O)CCCCCCC(C(=O)OCC)S(=O)(=O)C1=CC=C(C)C=C1 OGBGRFOKRVIXOX-UHFFFAOYSA-N 0.000 description 1
- UZWFHJQDIUKAOY-UHFFFAOYSA-N ethyl 4-[2-(4-chlorophenyl)ethoxy]-2-(4-methylphenyl)sulfonylbutanoate Chemical compound C=1C=C(C)C=CC=1S(=O)(=O)C(C(=O)OCC)CCOCCC1=CC=C(Cl)C=C1 UZWFHJQDIUKAOY-UHFFFAOYSA-N 0.000 description 1
- PQJJJMRNHATNKG-UHFFFAOYSA-N ethyl bromoacetate Chemical compound CCOC(=O)CBr PQJJJMRNHATNKG-UHFFFAOYSA-N 0.000 description 1
- 125000004705 ethylthio group Chemical group C(C)S* 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- JJWLVOIRVHMVIS-UHFFFAOYSA-N isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 description 1
- 125000000468 ketone group Chemical group 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 229960002900 methylcellulose Drugs 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 125000002560 nitrile group Chemical group 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229940124531 pharmaceutical excipient Drugs 0.000 description 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 1
- 125000003356 phenylsulfanyl group Chemical group [*]SC1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000137 polyphosphoric acid Polymers 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 229910001923 silver oxide Inorganic materials 0.000 description 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
- DAYKJFVIXLSLSS-UHFFFAOYSA-M sodium;3-methylbenzenesulfinate Chemical compound [Na+].CC1=CC=CC(S([O-])=O)=C1 DAYKJFVIXLSLSS-UHFFFAOYSA-M 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 150000003457 sulfones Chemical class 0.000 description 1
- 125000002130 sulfonic acid ester group Chemical group 0.000 description 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 1
- 150000003462 sulfoxides Chemical class 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- YBRBMKDOPFTVDT-UHFFFAOYSA-N tert-butylamine Chemical compound CC(C)(C)N YBRBMKDOPFTVDT-UHFFFAOYSA-N 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- JABYJIQOLGWMQW-UHFFFAOYSA-N undec-4-ene Chemical compound CCCCCCC=CCCC JABYJIQOLGWMQW-UHFFFAOYSA-N 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C313/00—Sulfinic acids; Sulfenic acids; Halides, esters or anhydrides thereof; Amides of sulfinic or sulfenic acids, i.e. compounds having singly-bound oxygen atoms of sulfinic or sulfenic groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C313/08—Sulfenic acids; Derivatives thereof
- C07C313/10—Sulfenic acids; Esters thereof
- C07C313/12—Sulfenic acids; Esters thereof having sulfur atoms of sulfenic groups bound to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/02—Sulfones; Sulfoxides having sulfone or sulfoxide groups bound to acyclic carbon atoms
- C07C317/04—Sulfones; Sulfoxides having sulfone or sulfoxide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Diaphragms For Electromechanical Transducers (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19873700729 DE3700729A1 (de) | 1987-01-13 | 1987-01-13 | Neue carbonsaeurederivate, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DD267036A5 true DD267036A5 (de) | 1989-04-19 |
Family
ID=6318733
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD88312165A DD267036A5 (de) | 1987-01-13 | 1988-01-11 | Verfahren zur herstellung von carbonsaeurederivaten |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US5145611A (cs) |
| EP (1) | EP0279162B1 (cs) |
| JP (1) | JPS63174948A (cs) |
| KR (1) | KR880008978A (cs) |
| CN (1) | CN1018548B (cs) |
| AT (1) | ATE64594T1 (cs) |
| AU (1) | AU605821B2 (cs) |
| CA (1) | CA1316933C (cs) |
| CS (1) | CS273338B2 (cs) |
| DD (1) | DD267036A5 (cs) |
| DE (2) | DE3700729A1 (cs) |
| DK (1) | DK12788A (cs) |
| ES (1) | ES2044977T3 (cs) |
| FI (1) | FI880120A7 (cs) |
| GR (1) | GR3002562T3 (cs) |
| HU (1) | HUT48195A (cs) |
| IL (1) | IL85068A0 (cs) |
| MX (1) | MX10083A (cs) |
| PT (1) | PT86531B (cs) |
| ZA (1) | ZA8886B (cs) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4111026A1 (de) * | 1991-04-05 | 1992-10-08 | Boehringer Mannheim Gmbh | Optisch aktive carbonsaeuren sowie diese enthaltende arzneimittel |
| US5260465A (en) * | 1991-12-16 | 1993-11-09 | Merck & Co., Inc. | Inhibitors of farnesyl protein transferase |
| US5284971A (en) * | 1992-07-16 | 1994-02-08 | Syntex (U.S.A.) Inc. | 4-(3-cyclohexyl-4-hydroxy or-methoxy phenylsulfonyl) 3,5 dibromo phenyl acetic thyromimetic cholesterol-lowering agents |
| DE10222104A1 (de) * | 2002-05-17 | 2003-12-04 | Helm Ag | Verfahren zur Herstellung von N-(4'-Cyano-3'-trifluormethyl)-3-(4"-fluorphenylsulfonyl)-2-hydroxy-2-methylpropionamid |
| JP2006519229A (ja) | 2003-02-13 | 2006-08-24 | アルバート・アインシュタイン・カレッジ・オヴ・メディシン・オヴ・イェシヴァ・ユニヴァーシティ | 視床下部内の長鎖脂肪アシルＣｏＡレベルの変調による摂食量およびグルコース産生量の調節 |
| JP5587969B2 (ja) * | 2009-03-18 | 2014-09-10 | オラテック インダストリーズ リミティド ライアビリティ カンパニー | 炎症及び疼痛の処置用の化合物 |
| CN103221386A (zh) | 2010-09-24 | 2013-07-24 | 兰贝克赛实验室有限公司 | 基质金属蛋白酶抑制剂 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3562330A (en) * | 1968-07-18 | 1971-02-09 | Parke Davis & Co | 2-phenoxy-4- and 5-phenyl-butyl and -pentyl-amines and salts |
| GB1382267A (en) * | 1970-05-05 | 1975-01-29 | Rorer Inc William H | Phenylalkanoic acid derivatives |
| GB2090591A (en) * | 1980-12-15 | 1982-07-14 | Ici Plc | Amide derivatives |
| DE3674014D1 (de) * | 1985-02-04 | 1990-10-18 | Searle & Co | Disubstituierte 4-hydroxyphenylthio-anilide. |
| DE3525284A1 (de) * | 1985-07-16 | 1987-01-29 | Boehringer Mannheim Gmbh | Neue carbonsaeurederivate, verfahren zu ihrer herstellung, ihre verwendung sowie arzneimittel, die diese verbindungen enthalten |
-
1987
- 1987-01-13 DE DE19873700729 patent/DE3700729A1/de not_active Withdrawn
- 1987-12-30 CA CA000555671A patent/CA1316933C/en not_active Expired - Fee Related
-
1988
- 1988-01-07 ES ES88100093T patent/ES2044977T3/es not_active Expired - Lifetime
- 1988-01-07 AT AT88100093T patent/ATE64594T1/de not_active IP Right Cessation
- 1988-01-07 DE DE8888100093T patent/DE3863297D1/de not_active Expired - Lifetime
- 1988-01-07 EP EP88100093A patent/EP0279162B1/de not_active Expired - Lifetime
- 1988-01-07 ZA ZA8886A patent/ZA8886B/xx unknown
- 1988-01-11 IL IL85068A patent/IL85068A0/xx unknown
- 1988-01-11 DD DD88312165A patent/DD267036A5/de unknown
- 1988-01-12 AU AU10199/88A patent/AU605821B2/en not_active Ceased
- 1988-01-12 DK DK012788A patent/DK12788A/da not_active Application Discontinuation
- 1988-01-12 CN CN88100219A patent/CN1018548B/zh not_active Expired
- 1988-01-12 CS CS21188A patent/CS273338B2/cs unknown
- 1988-01-12 US US07/143,456 patent/US5145611A/en not_active Expired - Fee Related
- 1988-01-12 HU HU88110A patent/HUT48195A/hu unknown
- 1988-01-12 PT PT86531A patent/PT86531B/pt not_active IP Right Cessation
- 1988-01-12 FI FI880120A patent/FI880120A7/fi not_active Application Discontinuation
- 1988-01-12 JP JP63003275A patent/JPS63174948A/ja active Pending
- 1988-01-13 KR KR1019880000244A patent/KR880008978A/ko not_active Ceased
- 1988-02-13 MX MX1008388A patent/MX10083A/es unknown
-
1991
- 1991-06-20 GR GR91400798T patent/GR3002562T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI880120A7 (fi) | 1988-07-14 |
| CN88100219A (zh) | 1988-07-27 |
| DE3700729A1 (de) | 1988-07-21 |
| GR3002562T3 (en) | 1993-01-25 |
| DK12788D0 (da) | 1988-01-12 |
| ZA8886B (en) | 1988-09-28 |
| EP0279162A1 (de) | 1988-08-24 |
| PT86531B (pt) | 1991-12-31 |
| CS273338B2 (en) | 1991-03-12 |
| ATE64594T1 (de) | 1991-07-15 |
| PT86531A (de) | 1988-02-01 |
| CN1018548B (zh) | 1992-10-07 |
| AU605821B2 (en) | 1991-01-24 |
| KR880008978A (ko) | 1988-09-13 |
| JPS63174948A (ja) | 1988-07-19 |
| CA1316933C (en) | 1993-04-27 |
| MX10083A (es) | 1993-12-01 |
| FI880120A0 (fi) | 1988-01-12 |
| EP0279162B1 (de) | 1991-06-19 |
| HUT48195A (en) | 1989-05-29 |
| CS21188A2 (en) | 1990-07-12 |
| DK12788A (da) | 1988-07-14 |
| ES2044977T3 (es) | 1994-01-16 |
| IL85068A0 (en) | 1988-06-30 |
| DE3863297D1 (de) | 1991-07-25 |
| AU1019988A (en) | 1988-08-04 |
| US5145611A (en) | 1992-09-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0031954B1 (de) | Neue Sulfonamide, Verfahren zu deren Herstellung sowie diese Verbindungen enthaltende Arzneimittel | |
| EP0226636B1 (de) | Neue carbonsäurederivate, verfahren zu ihrer herstellung, ihre verwendung sowie arzneimittel, die diese verbindungen enthalten | |
| DE3920616A1 (de) | Arzneimittel, enthaltend di-tert.-butylhydroxyphenyl-derivate sowie neue derivate | |
| EP0353448A1 (de) | Sulfonamide, Verfahren zu ihrer Herstellung sowie diese Verbindungen enthaltende Arzneimittel | |
| EP0384279B1 (de) | Benzolsulfonamide und Verfahren zu ihrer Herstellung | |
| DD267036A5 (de) | Verfahren zur herstellung von carbonsaeurederivaten | |
| EP0025192A2 (de) | Substituierte Oxirancarbonsäuren, Verfahren zu ihrer Herstellung, ihre Verwendung und sie enthaltende Arzneimittel | |
| EP0046961B1 (de) | Epoxi-cycloalkylalkancarbonsäuren, Verfahren zu ihrer Herstellung, ihre Verwendung sowie sie enthaltende Arzneimittel | |
| DE69703791T2 (de) | Diphenylstibene als prodrugs zu cox-2-inhibitoren | |
| EP0275024B1 (de) | Neue Carbonsäurederivate, Verfahren zu ihrer Herstellung sowie Arzneimittel, die diese Verbindungen enthalten | |
| DE4111026A1 (de) | Optisch aktive carbonsaeuren sowie diese enthaltende arzneimittel | |
| DE3632893A1 (de) | 4-(r)-hydroxy-6(s)-arylthiomethyl-tetrahydropyran-2-one, deren entsprechende sulfoxide und sulfone, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel, pharmazeutische praeparate und zwischenprodukte | |
| DE10142662A1 (de) | Derivate von C2-substituierte Indan-1-ol-Systemen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel | |
| EP0149201B1 (de) | Neue Carbonsäure-Derivate, Verfahren zu ihrer Herstellung sowie diese Verbindungen enthaltende Arzneimittel | |
| DE2322125A1 (de) | Substituierte 1-hydroxy-3-(2-naphthyl) ketone und deren derivate | |
| DE10142667B4 (de) | C2-substituierte Indan-1-ole und ihre Derivate und ihre Verwendung als Arzneimittel | |
| CH635314A5 (de) | Verfahren zur herstellung von 2-(phenylalkylhydrazono)-propionsaeurederivaten. | |
| DE2406812A1 (de) | 2-(3,5-di-tert-butylphenyl)-(thio- oder sulfonyl-)- alkancarbonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel | |
| DE10142663A1 (de) | C2-Disubstituierte Indan -1-ol-Systeme, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel | |
| DE10142661A1 (de) | Mehrfach substituierte Indan-1-ol-Systeme, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel | |
| EP1425267A2 (de) | C2-substituierte indan-1-one und ihre derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
| EP0303181A2 (de) | 1,2-Diamino-Verbindungen, Verfahren zu ihrer Herstellung sowie Arzneimittel, die diese Verbindungen enthalten | |
| WO1997030018A1 (de) | 2,2-difluoralkancarbonsäuren, verfahren zu ihrer herstellung und diese enthaltende arzneimittel | |
| DE2145932A1 (de) | Biphenylenessigsaure | |
| CH540278A (de) | Verfahren zur Herstellung von neuen Morpholinderivaten und deren Säureadditionssalzen |